UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

The European respiratory journal, 2018-06, Vol.51 (6), p.1800602-1800602

Uguen, Arnaud

2018

Volltextzugriff (PDF)

Asbestos-related lung cancers are rarely associated with ALK , ROS1 and RET rearrangements

The European respiratory journal, 2018-03, Vol.51 (3), p.1702605-1702605

2018

Volltextzugriff (PDF)

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

Journal of clinical pathology, 2018-09, Vol.71 (9), p.757-762

2018

Volltextzugriff (PDF)

Random Colocalization and Split of ALK Break Apart Probe Signals: Potential Concerns in the Real‐Life Diagnosis of Non‐Small‐Cell Lung Cancer

Cytometry. Part A, 2018-10, Vol.93 (10), p.980-981

Uguen, Arnaud

2018

Volltextzugriff (PDF)

ROS1 fusions in cancer: a review

Future Oncology, 2016-08, Vol.12 (16), p.1911-1928

2016

Volltextzugriff (PDF)

Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories

Journal of clinical pathology, 2019-12, Vol.72 (12), p.830-835

2019

Volltextzugriff (PDF)

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view

Journal of clinical pathology, 2017-10, Vol.70 (10), p.906-907

2017

Volltextzugriff (PDF)

NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?/Reply

Archives of pathology & laboratory medicine (1976), 2018-12, Vol.142 (12), p.1451-1452

2018

Volltextzugriff (PDF)

The rarity of concomitant genetic alterations in lung cancer

Modern pathology, 2018-03, Vol.31 (3), p.539-540

2018

Volltextzugriff (PDF)

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Human pathology, 2021-08, Vol.114, p.99-109

2021

Volltextzugriff (PDF)

About concomitant KRAS and other molecular alterations in non–small cell lung cancers

Human pathology, 2019-05, Vol.87, p.115-116

2019

Volltextzugriff (PDF)

Costs of ALK, ROS1, EGFR, and KRAS testing in non–small cell lung cancer: About different strategies in France

Cancer cytopathology, 2017-11, Vol.125 (11), p.876-876

2017

Volltextzugriff (PDF)

Mismatch repair–deficient colorectal cancer: a model of immunogenic and immune cell–rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells

Human pathology, 2018-02, Vol.72, p.135-143

2018

Volltextzugriff (PDF)

About MET expression and other biomarkers in non-small cell lung cancer

Virchows Archiv : an international journal of pathology, 2017-11, Vol.471 (5), p.685-686

2017

Volltextzugriff (PDF)

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

The European respiratory journal, 2018-06, Vol.51 (6), p.1800844-1800844

2018

Volltextzugriff (PDF)

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

BMC cancer, 2016-03, Vol.16 (208), p.210-210, Article 210

2016

Volltextzugriff (PDF)

ALK -rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?

Lung cancer (Amsterdam, Netherlands), 2016-01, Vol.91, p.67-69

2016

Volltextzugriff (PDF)

False ALK Rearrangement Signals in Inflammatory Cells: A Pitfall in the Interpretation of ALK Fluorescence In Situ Hybridization in Non-Small Cell Lung Cancer

Applied immunohistochemistry & molecular morphology, 2017-10, Vol.25 (9), p.668-670

2017

Volltextzugriff (PDF)

Asbestos-related lung cancers: A retrospective clinical and pathological study

Molecular and clinical oncology, 2017-07, Vol.7 (1), p.135-139

2017

Volltextzugriff (PDF)

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues

Oncology reports, 2016-09, Vol.36 (3), p.1427-1434

2016

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

ThemaLung Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Mutation
(11)
Pathology
(11)
Humans
(9)
Tumors
(7)
Laboratories
(6)
Oncology
(6)
Automation
(5)
Colorectal Cancer
(5)
Female
(5)
Immunohistochemistry
(5)
Aged
(4)
Biomarkers
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)
Immunotherapy
(4)
Metastasis
(4)
Middle Aged
(4)
Non-Small Cell Lung Carcinoma
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

Asbestos-related lung cancers are rarely associated with ALK , ROS1 and RET rearrangements

A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day

Random Colocalization and Split of ALK Break Apart Probe Signals: Potential Concerns in the Real‐Life Diagnosis of Non‐Small‐Cell Lung Cancer

ROS1 fusions in cancer: a review

Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view

NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?/Reply

The rarity of concomitant genetic alterations in lung cancer

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

About concomitant KRAS and other molecular alterations in non–small cell lung cancers

Costs of ALK, ROS1, EGFR, and KRAS testing in non–small cell lung cancer: About different strategies in France

Mismatch repair–deficient colorectal cancer: a model of immunogenic and immune cell–rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells

About MET expression and other biomarkers in non-small cell lung cancer

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

ALK -rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?

False ALK Rearrangement Signals in Inflammatory Cells: A Pitfall in the Interpretation of ALK Fluorescence In Situ Hybridization in Non-Small Cell Lung Cancer

Asbestos-related lung cancers: A retrospective clinical and pathological study

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues

Aktive Filter

Suchergebnisse filtern